nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—Allergic cutaneous angiitis—Sorafenib—liver cancer	0.0541	0.174	CcSEcCtD
Bendroflumethiazide—TPMT—Phase II conjugation—UGDH—liver cancer	0.036	0.0523	CbGpPWpGaD
Bendroflumethiazide—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.0351	0.113	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—UGDH—liver cancer	0.0211	0.0306	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTA3—liver cancer	0.0207	0.03	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTA4—liver cancer	0.0189	0.0275	CbGpPWpGaD
Bendroflumethiazide—Drug interaction—Sorafenib—liver cancer	0.0186	0.0598	CcSEcCtD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTA2—liver cancer	0.0185	0.0268	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTA1—liver cancer	0.0178	0.0258	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—NAT2—liver cancer	0.0176	0.0255	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—SIX3—liver cancer	0.0174	0.0252	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—HPGDS—liver cancer	0.0141	0.0204	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—NR1H4—liver cancer	0.0123	0.0179	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GSTA3—liver cancer	0.0121	0.0176	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTA3—liver cancer	0.0119	0.0173	CbGpPWpGaD
Bendroflumethiazide—Hypokalaemia—Sorafenib—liver cancer	0.0114	0.0367	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—GSTA4—liver cancer	0.0111	0.0161	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTA4—liver cancer	0.0109	0.0158	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GSTA2—liver cancer	0.0108	0.0157	CbGpPWpGaD
Bendroflumethiazide—Pancreatitis—Sorafenib—liver cancer	0.0106	0.0341	CcSEcCtD
Bendroflumethiazide—TPMT—Phase II conjugation—GGT1—liver cancer	0.0105	0.0153	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GSTA1—liver cancer	0.0104	0.0151	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—NAT2—liver cancer	0.0103	0.0149	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—NAT2—liver cancer	0.0102	0.0147	CbGpPWpGaD
Bendroflumethiazide—Erectile dysfunction—Sorafenib—liver cancer	0.00995	0.0321	CcSEcCtD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTP1—liver cancer	0.00946	0.0137	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTM1—liver cancer	0.00869	0.0126	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GPX3—liver cancer	0.00864	0.0125	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00858	0.0124	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00851	0.0123	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00851	0.0123	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—HPGDS—liver cancer	0.00823	0.0119	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00818	0.0119	CbGpPWpGaD
Bendroflumethiazide—Blood disorder—Epirubicin—liver cancer	0.00762	0.0246	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Sorafenib—liver cancer	0.00724	0.0233	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—HBE1—liver cancer	0.00707	0.0102	CbGpPWpGaD
Bendroflumethiazide—Blood disorder—Doxorubicin—liver cancer	0.00705	0.0227	CcSEcCtD
Bendroflumethiazide—KCNMA1—Neuronal System—GLUL—liver cancer	0.00689	0.00999	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—CYP2E1—liver cancer	0.00671	0.00973	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP2E1—liver cancer	0.00662	0.0096	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—AHR—liver cancer	0.00661	0.00958	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GGT1—liver cancer	0.00616	0.00893	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Platelet homeostasis—MAPK14—liver cancer	0.00609	0.00883	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Sorafenib—liver cancer	0.00601	0.0194	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—GSTM1—liver cancer	0.006	0.0087	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Sorafenib—liver cancer	0.00585	0.0189	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—GSTP1—liver cancer	0.00554	0.00803	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTP1—liver cancer	0.00546	0.00792	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Sorafenib—liver cancer	0.00534	0.0172	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Epirubicin—liver cancer	0.00531	0.0171	CcSEcCtD
Bendroflumethiazide—Constipation—Sorafenib—liver cancer	0.00525	0.0169	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Epirubicin—liver cancer	0.00516	0.0166	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—GSTM1—liver cancer	0.00509	0.00737	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTM1—liver cancer	0.00502	0.00727	CbGpPWpGaD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—liver cancer	0.00491	0.0158	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—CYP1A1—liver cancer	0.00482	0.00699	CbGpPWpGaD
Bendroflumethiazide—Purpura—Epirubicin—liver cancer	0.00479	0.0154	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—liver cancer	0.00478	0.0154	CcSEcCtD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP1A1—liver cancer	0.00476	0.0069	CbGpPWpGaD
Bendroflumethiazide—Purpura—Doxorubicin—liver cancer	0.00443	0.0143	CcSEcCtD
Bendroflumethiazide—Asthenia—Sorafenib—liver cancer	0.00441	0.0142	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—ANXA2—liver cancer	0.00437	0.00633	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00436	0.00632	CbGpPWpGaD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—liver cancer	0.00422	0.0136	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—liver cancer	0.0042	0.0135	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Sorafenib—liver cancer	0.0042	0.0135	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00416	0.00603	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Sorafenib—liver cancer	0.00406	0.0131	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00399	0.00578	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00399	0.00578	CbGpPWpGaD
Bendroflumethiazide—Pancreatitis—Epirubicin—liver cancer	0.00391	0.0126	CcSEcCtD
Bendroflumethiazide—Vomiting—Sorafenib—liver cancer	0.00391	0.0126	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—liver cancer	0.0039	0.0126	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—liver cancer	0.00389	0.0125	CcSEcCtD
Bendroflumethiazide—Rash—Sorafenib—liver cancer	0.00387	0.0125	CcSEcCtD
Bendroflumethiazide—Dermatitis—Sorafenib—liver cancer	0.00387	0.0125	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00377	0.00547	CbGpPWpGaD
Bendroflumethiazide—Nausea—Sorafenib—liver cancer	0.00365	0.0118	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—liver cancer	0.00362	0.0117	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN2A—liver cancer	0.00362	0.00524	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—UGDH—liver cancer	0.00361	0.00523	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—EPT1—liver cancer	0.00339	0.00492	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TAT—liver cancer	0.00321	0.00466	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN1B—liver cancer	0.0032	0.00464	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PPARA—liver cancer	0.00309	0.00448	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CCND1—liver cancer	0.00305	0.00443	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN1A—liver cancer	0.00296	0.00428	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SERPINA1—liver cancer	0.00289	0.00419	CbGpPWpGaD
Bendroflumethiazide—Muscle spasms—Epirubicin—liver cancer	0.00267	0.00862	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—UGDH—liver cancer	0.00261	0.00378	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PPARG—liver cancer	0.00256	0.00371	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—UGDH—liver cancer	0.0025	0.00362	CbGpPWpGaD
Bendroflumethiazide—Muscle spasms—Doxorubicin—liver cancer	0.00247	0.00797	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—EPT1—liver cancer	0.00245	0.00355	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—MYC—liver cancer	0.00245	0.00355	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UGDH—liver cancer	0.0024	0.00347	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EPT1—liver cancer	0.00235	0.00341	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TAT—liver cancer	0.00232	0.00337	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—SERPINE1—liver cancer	0.0023	0.00334	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—KRAS—liver cancer	0.00226	0.00328	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EPT1—liver cancer	0.00225	0.00327	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TAT—liver cancer	0.00223	0.00323	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—liver cancer	0.00222	0.00716	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—GLUL—liver cancer	0.00219	0.00317	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CPT1B—liver cancer	0.00219	0.00317	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Epirubicin—liver cancer	0.00216	0.00697	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA1—liver cancer	0.00215	0.00312	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TAT—liver cancer	0.00214	0.0031	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Epirubicin—liver cancer	0.00212	0.00684	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—NR1H4—liver cancer	0.00211	0.00305	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA3—liver cancer	0.00207	0.003	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—liver cancer	0.00206	0.00663	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—liver cancer	0.002	0.00645	CcSEcCtD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—liver cancer	0.00197	0.00286	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Epirubicin—liver cancer	0.00197	0.00636	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—liver cancer	0.00196	0.00633	CcSEcCtD
Bendroflumethiazide—Constipation—Epirubicin—liver cancer	0.00194	0.00626	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—HRAS—liver cancer	0.00192	0.00279	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CYCS—liver cancer	0.00192	0.00279	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—BRAF—liver cancer	0.00192	0.00278	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PRKCE—liver cancer	0.00191	0.00276	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA4—liver cancer	0.00189	0.00275	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA2—liver cancer	0.00185	0.00268	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Doxorubicin—liver cancer	0.00183	0.00588	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—JUN—liver cancer	0.00181	0.00263	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ABL1—liver cancer	0.00181	0.00263	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF2—liver cancer	0.0018	0.00262	CbGpPWpGaD
Bendroflumethiazide—Constipation—Doxorubicin—liver cancer	0.0018	0.00579	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—GSTA1—liver cancer	0.00178	0.00258	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NAT2—liver cancer	0.00176	0.00255	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—MAPK8—liver cancer	0.00172	0.00249	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HGF—liver cancer	0.0017	0.00247	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALDOB—liver cancer	0.00169	0.00245	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CSF2—liver cancer	0.00169	0.00244	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00167	0.00242	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Epirubicin—liver cancer	0.00163	0.00525	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—CRABP1—liver cancer	0.00161	0.00234	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—RAF1—liver cancer	0.0016	0.00232	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GLUL—liver cancer	0.00158	0.00229	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CPT1B—liver cancer	0.00158	0.00229	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Epirubicin—liver cancer	0.00155	0.00501	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—NR1H4—liver cancer	0.00152	0.00221	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GLUL—liver cancer	0.00151	0.0022	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CPT1B—liver cancer	0.00151	0.0022	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Doxorubicin—liver cancer	0.00151	0.00486	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—liver cancer	0.0015	0.00484	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—GSTA3—liver cancer	0.0015	0.00217	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NR1H4—liver cancer	0.00146	0.00212	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GLUL—liver cancer	0.00145	0.00211	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CPT1B—liver cancer	0.00145	0.00211	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Epirubicin—liver cancer	0.00144	0.00465	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—liver cancer	0.00144	0.00463	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GSTA3—liver cancer	0.00144	0.00208	CbGpPWpGaD
Bendroflumethiazide—Rash—Epirubicin—liver cancer	0.00143	0.00461	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—liver cancer	0.00143	0.00461	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—HPGDS—liver cancer	0.00141	0.00204	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NR1H4—liver cancer	0.0014	0.00203	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Doxorubicin—liver cancer	0.00139	0.00448	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—GSTA3—liver cancer	0.00138	0.002	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA4—liver cancer	0.00137	0.00199	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK14—liver cancer	0.00136	0.00198	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.00135	0.00196	CbGpPWpGaD
Bendroflumethiazide—Nausea—Epirubicin—liver cancer	0.00135	0.00435	CcSEcCtD
Bendroflumethiazide—Vomiting—Doxorubicin—liver cancer	0.00134	0.0043	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—GSTA2—liver cancer	0.00133	0.00194	CbGpPWpGaD
Bendroflumethiazide—Rash—Doxorubicin—liver cancer	0.00132	0.00427	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—liver cancer	0.00132	0.00426	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—F2—liver cancer	0.00132	0.00192	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA4—liver cancer	0.00131	0.0019	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA1—liver cancer	0.00129	0.00187	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA2—liver cancer	0.00128	0.00186	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NAT2—liver cancer	0.00127	0.00185	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CG—liver cancer	0.00127	0.00183	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA4—liver cancer	0.00126	0.00183	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PSMD10—liver cancer	0.00125	0.00182	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PSMA4—liver cancer	0.00125	0.00182	CbGpPWpGaD
Bendroflumethiazide—Nausea—Doxorubicin—liver cancer	0.00125	0.00402	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GSTA1—liver cancer	0.00123	0.00179	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA2—liver cancer	0.00123	0.00178	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NAT2—liver cancer	0.00122	0.00177	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GOT2—liver cancer	0.00122	0.00177	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALDOB—liver cancer	0.00122	0.00177	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—liver cancer	0.0012	0.00174	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA1—liver cancer	0.00118	0.00172	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALDOB—liver cancer	0.00117	0.0017	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NAT2—liver cancer	0.00117	0.0017	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CRABP1—liver cancer	0.00116	0.00169	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2E1—liver cancer	0.00115	0.00166	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALDOB—liver cancer	0.00112	0.00163	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CRABP1—liver cancer	0.00112	0.00162	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CD—liver cancer	0.00111	0.00161	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SERPINE1—liver cancer	0.0011	0.0016	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—liver cancer	0.0011	0.00159	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—liver cancer	0.0011	0.00159	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYCS—liver cancer	0.00107	0.00156	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CRABP1—liver cancer	0.00107	0.00155	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GOT1—liver cancer	0.00105	0.00153	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GGT1—liver cancer	0.00105	0.00153	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HPGDS—liver cancer	0.00102	0.00148	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—liver cancer	0.001	0.00145	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RAF1—liver cancer	0.000993	0.00144	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HPGDS—liver cancer	0.000976	0.00142	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CB—liver cancer	0.00097	0.00141	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—liver cancer	0.000947	0.00137	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HPGDS—liver cancer	0.000936	0.00136	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMOX1—liver cancer	0.000934	0.00135	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PSMA4—liver cancer	0.000907	0.00132	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PSMD10—liver cancer	0.000907	0.00132	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000907	0.00132	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—liver cancer	0.000891	0.00129	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GOT2—liver cancer	0.000883	0.00128	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HRAS—liver cancer	0.000881	0.00128	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PSMD10—liver cancer	0.00087	0.00126	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PSMA4—liver cancer	0.00087	0.00126	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—liver cancer	0.00087	0.00126	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GOT2—liver cancer	0.000846	0.00123	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PSMD10—liver cancer	0.000834	0.00121	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PSMA4—liver cancer	0.000834	0.00121	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2E1—liver cancer	0.00083	0.0012	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1A1—liver cancer	0.000825	0.0012	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GOT2—liver cancer	0.000811	0.00118	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2E1—liver cancer	0.000796	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYCS—liver cancer	0.000776	0.00113	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—liver cancer	0.000769	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2E1—liver cancer	0.000763	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GOT1—liver cancer	0.000762	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GGT1—liver cancer	0.000762	0.0011	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—liver cancer	0.000757	0.0011	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARA—liver cancer	0.000754	0.00109	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYCS—liver cancer	0.000744	0.00108	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GGT1—liver cancer	0.00073	0.00106	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GOT1—liver cancer	0.00073	0.00106	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYCS—liver cancer	0.000714	0.00103	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GGT1—liver cancer	0.0007	0.00102	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GOT1—liver cancer	0.0007	0.00102	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TGFB1—liver cancer	0.000695	0.00101	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—liver cancer	0.000684	0.000992	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HMOX1—liver cancer	0.000675	0.000979	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—liver cancer	0.000656	0.000951	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMOX1—liver cancer	0.000647	0.000938	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CG—liver cancer	0.000646	0.000936	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—liver cancer	0.000643	0.000933	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—liver cancer	0.000629	0.000912	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—liver cancer	0.000629	0.000912	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARG—liver cancer	0.000623	0.000904	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMOX1—liver cancer	0.00062	0.000899	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—liver cancer	0.000603	0.000874	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1A1—liver cancer	0.000596	0.000864	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CA—liver cancer	0.000591	0.000857	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—liver cancer	0.000578	0.000838	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—liver cancer	0.000572	0.000829	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1A1—liver cancer	0.000572	0.000829	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CD—liver cancer	0.000568	0.000823	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—liver cancer	0.000561	0.000813	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—liver cancer	0.000556	0.000806	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1A1—liver cancer	0.000548	0.000795	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HRAS—liver cancer	0.000547	0.000793	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARA—liver cancer	0.000545	0.000791	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—liver cancer	0.000533	0.000773	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARA—liver cancer	0.000523	0.000758	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—liver cancer	0.000511	0.000741	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARA—liver cancer	0.000501	0.000727	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CB—liver cancer	0.000495	0.000718	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—liver cancer	0.000483	0.0007	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CG—liver cancer	0.000467	0.000677	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARG—liver cancer	0.000451	0.000653	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CG—liver cancer	0.000448	0.000649	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARG—liver cancer	0.000432	0.000626	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CG—liver cancer	0.000429	0.000622	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARG—liver cancer	0.000414	0.000601	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CD—liver cancer	0.000411	0.000595	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—liver cancer	0.000405	0.000588	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CD—liver cancer	0.000394	0.000571	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—liver cancer	0.000389	0.000563	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CD—liver cancer	0.000377	0.000547	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—liver cancer	0.000373	0.00054	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CB—liver cancer	0.000358	0.000519	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CB—liver cancer	0.000343	0.000497	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CB—liver cancer	0.000329	0.000477	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CA—liver cancer	0.000302	0.000437	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—liver cancer	0.000246	0.000357	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CA—liver cancer	0.000218	0.000316	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CA—liver cancer	0.000209	0.000303	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CA—liver cancer	0.000201	0.000291	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—liver cancer	0.000178	0.000258	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—liver cancer	0.000171	0.000248	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—liver cancer	0.000164	0.000237	CbGpPWpGaD
